mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
-0.31 |
0.03 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.03 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.03 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.03 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.03 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.03 |